Poly Medicure

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE205C01021
  • NSEID: POLYMED
  • BSEID: 531768
INR
1,519.95
7.5 (0.5%)
BSENSE

Jun 16, 10:23 AM

BSE+NSE Vol: 13.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
534.51
493.66
443.88
403.21
440.83
424.21
420.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
534.51
493.66
443.88
403.21
440.83
424.21
420.02
Raw Material Cost
155.08
146.17
157.07
141.07
141.95
141.95
154.88
Purchase of Finished goods
1.38
1.58
1.23
0.86
2.51
3.32
1.21
(Increase) / Decrease In Stocks
21.70
8.01
-22.65
-14.70
2.93
1.23
-23.57
Employee Cost
126.14
115.20
88.83
75.11
78.89
76.23
78.09
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
6.74
5.96
7.81
6.68
6.62
5.85
5.30
Other Expenses
113.08
105.55
96.90
88.48
88.47
81.22
88.92
Total Expenditure (Excl Depreciation)
424.12
382.47
329.20
297.50
321.37
309.81
304.83
Operating Profit (PBDIT) excl Other Income
110.39
111.19
114.68
105.71
119.46
114.40
115.19
Other Income
17.76
26.26
33.94
42.12
24.31
21.80
26.10
Operating Profit (PBDIT)
128.15
137.45
148.62
147.83
143.77
136.20
141.29
Interest
6.41
5.96
2.97
2.95
2.17
3.33
3.34
Exceptional Items
0.00
-6.80
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
121.74
124.69
145.65
144.88
141.60
132.87
137.95
Depreciation
38.23
28.76
24.93
23.26
21.03
21.37
20.71
Profit Before Tax
85.22
97.61
121.69
122.95
122.85
113.23
117.98
Tax
20.18
26.80
29.89
29.86
31.02
28.00
30.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
63.33
69.12
90.84
91.76
89.55
83.51
86.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
63.33
69.12
90.84
91.76
89.55
83.51
86.70
Share in Profit of Associates
1.71
1.69
0.96
1.32
2.28
1.72
0.75
Minority Interest
-1.25
-0.12
-0.04
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
66.29
70.93
91.84
93.08
91.83
85.23
87.45
Equity Capital
50.68
50.68
50.68
50.66
50.66
50.66
50.65
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
2,540.62
Earnings per share (EPS)
6.54
7.0
9.06
9.19
9.06
8.41
8.63
Diluted Earnings per share
6.53
6.99
9.06
9.17
8.92
8.48
9.01
Operating Profit Margin (Excl OI)
20.65%
22.52%
25.84%
26.22%
27.1%
26.97%
27.42%
Gross Profit Margin
22.78%
25.26%
32.81%
35.93%
32.12%
31.32%
32.84%
PAT Margin
12.17%
14.34%
20.68%
23.08%
20.83%
20.09%
20.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 21.25% vs 16.60% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -27.81% vs 34.33% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -7.59% vs 23.84% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 195.39% vs -30.45% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Poly Medicure With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
534.51
1,036.50
-501.99
-48.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
534.51
1,036.50
-501.99
-48.43%
Raw Material Cost
155.08
223.30
-68.22
-30.55%
Purchase of Finished goods
1.38
0.00
1.38
(Increase) / Decrease In Stocks
21.70
9.80
11.90
121.43%
Employee Cost
126.14
300.80
-174.66
-58.07%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
6.74
0.00
6.74
Other Expenses
113.08
199.20
-86.12
-43.23%
Total Expenditure (Excl Depreciation)
424.12
733.10
-308.98
-42.15%
Operating Profit (PBDIT) excl Other Income
110.39
303.40
-193.01
-63.62%
Other Income
17.76
22.20
-4.44
-20.00%
Operating Profit (PBDIT)
128.15
325.60
-197.45
-60.64%
Interest
6.41
12.10
-5.69
-47.02%
Exceptional Items
0.00
-6.00
6.00
100.00%
Gross Profit (PBDT)
121.74
307.50
-185.76
-60.41%
Depreciation
38.23
111.50
-73.27
-65.71%
Profit Before Tax
85.22
196.00
-110.78
-56.52%
Tax
20.18
48.10
-27.92
-58.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
63.33
147.90
-84.57
-57.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
63.33
147.90
-84.57
-57.18%
Share in Profit of Associates
1.71
0.00
1.71
Minority Interest
-1.25
0.00
-1.25
Other related items
0.00
0.00
0.00
Consolidated Net Profit
66.29
147.90
-81.61
-55.18%
Equity Capital
50.68
402.90
-352.22
-87.42%
Face Value
5.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.54
3.67
2.87
78.20%
Diluted Earnings per share
6.53
3.67
2.86
77.93%
Operating Profit Margin (Excl OI)
20.65%
29.27%
0.00
-8.62%
Gross Profit Margin
22.78%
29.67%
0.00
-6.89%
PAT Margin
12.17%
14.27%
0.00
-2.10%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 534.51 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.27% vs 11.21% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.25% vs 16.60% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 66.29 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.54% vs -22.77% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -27.81% vs 34.33% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 110.39 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -0.72% vs -3.04% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -7.59% vs 23.84% in Mar 2025

Quarterly - Interest
Interest 6.41 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 7.55% vs 100.67% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 195.39% vs -30.45% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.65%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025